Sophie G Shifman (Sophie Shifman)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Oxide Nanoparticles

Positive Breast Cancer

Drug Administration

Top Venues

The Journal of pharmacology and experimental therapeutics

The Journal of chemical physics

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Justin Fang, Nathaniel Hurley, Chia Te Chien, Alan Guo, Tamor A Khan, Mingxing Li, Mircea Cotlet, Federico Moretti, Edith Bourret, Sophie G Shifman, Stella E Tsirka, Maya Shelly, Stanislaus S Wong
Probing the optical properties and toxicological profile of zinc tungstate nanorods. The Journal of chemical physics 160 (23) (2024)
Daniel P Radin, Sophie G Shifman, Ian R Outhwaite, Aryan Sharma, Robert Bases, Markus A Seeliger, Stella E Tsirka
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Daniel P Radin, Sophie G Shifman, Ian R Outhwaite, Aryan Sharma, Robert Bases, Markus A Seeliger, Stella E Tsirka
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Justin Fang, Nathaniel Hurley, Chia Te Chien, Alan Guo, Tamor A Khan, Mingxing Li, Mircea Cotlet, Federico Moretti, Edith Bourret, Sophie G Shifman, Stella E Tsirka, Maya Shelly, Stanislaus S Wong
Probing the optical properties and toxicological profile of zinc tungstate nanorods. The Journal of chemical physics 160 (23) (2024)
Daniel P Radin, Sophie G Shifman, Ian R Outhwaite, Aryan Sharma, Robert Bases, Markus A Seeliger, Stella E Tsirka
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Daniel P Radin, Sophie G Shifman, Ian R Outhwaite, Aryan Sharma, Robert Bases, Markus A Seeliger, Stella E Tsirka
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Justin Fang, Nathaniel Hurley, Chia Te Chien, Alan Guo, Tamor A Khan, Mingxing Li, Mircea Cotlet, Federico Moretti, Edith Bourret, Sophie G Shifman, Stella E Tsirka, Maya Shelly, Stanislaus S Wong
Probing the optical properties and toxicological profile of zinc tungstate nanorods. The Journal of chemical physics 160 (23) (2024)
Daniel P Radin, Sophie G Shifman, Ian R Outhwaite, Aryan Sharma, Robert Bases, Markus A Seeliger, Stella E Tsirka
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Daniel P Radin, Sophie G Shifman, Ian R Outhwaite, Aryan Sharma, Robert Bases, Markus A Seeliger, Stella E Tsirka
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Daniel P Radin, Sophie G Shifman, Ian R Outhwaite, Aryan Sharma, Robert Bases, Markus A Seeliger, Stella E Tsirka
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Justin Fang, Nathaniel Hurley, Chia Te Chien, Alan Guo, Tamor A Khan, Mingxing Li, Mircea Cotlet, Federico Moretti, Edith Bourret, Sophie G Shifman, Stella E Tsirka, Maya Shelly, Stanislaus S Wong
Probing the optical properties and toxicological profile of zinc tungstate nanorods. The Journal of chemical physics 160 (23) (2024)
Emiliano Cocco, F Javier Carmona, Pedram Razavi, Helen H Won, Yanyan Cai, Valentina Rossi, Carmen Chan, James Cownie, Joanne Soong, Eneda Toska, Sophie G Shifman, Ivana Sarotto, Peter Savas, Michael J Wick, Kyriakos P Papadopoulos, Alyssa Moriarty, Richard E Cutler, Francesca Avogadri-Connors, Alshad S Lalani, Richard P Bryce, Sarat Chandarlapaty, David M Hyman, David B Solit, Valentina Boni, Sherene Loi, Jose Baselga, Michael F Berger, Filippo Montemurro, Maurizio Scaltriti
Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2). Science signaling 11 (551) (2018)